NCT02545556

Liver Cancer HepaSphere Combined With Cryosurgery

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）Combined With Cryosurgery for Liver Cancer: Clinical Trial

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Fuda Cancer Hospital, Guangzhou · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of HepaSphere interventional therapy using digital subtraction angiography（DSA）combined with cryosurgery for liver cancer.

Detailed description

By enrolling patients with liver cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of HepaSphere interventional therapy using digital subtraction angiography（DSA） combined with cryosurgery for liver cancer.

Conditions

• Liver Cancer

Interventions

Type	Name	Description
PROCEDURE	HepaSphere combined with cryosurgery	liver cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）combined with cryosurgery

Timeline

• Start date: 2015-08-01
• Primary completion: 2016-08-01
• Completion: 2016-08-01
• First posted: 2015-09-10
• Last updated: 2016-08-29

Locations

1 site across 1 country: China